Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis-Reference-Cited by-同舟云学术

Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis

Published:2016-04-07 Issue:4 Volume:17 Page:524
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rau Kun-Ming,Chen Han-Ku,Shiu Li-Yen,Chao Tsai-Ling,Lo Yi-Ping,Wang Chin-Chou,Lin Meng-Chih,Huang Chao-Cheng

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/4/524/pdf

Reference50 articles.

1. Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

2. Worldwide trends in lung cancer pathology

3. Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

4. Management of non-small-cell lung cancer: recent developments

5. EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the T790M mutation in non-small cell lung cancer (NSCLC) using brain metastasis MR radiomics: a study with an imbalanced dataset;Discover Oncology;2024-09-14

2. Comprehensive genomic and clinical analyses identify APOBEC mutational signatures as a brain metastasis risk factor in lung adenocarcinoma patients;Translational Oncology;2024-05

3. Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer;Japanese Journal of Clinical Oncology;2024-01-05

4. Single-center study on clinicopathological and typical molecular pathologic features of metastatic brain tumor;Journal of Pathology and Translational Medicine;2023-07-15

5. Preoperative Prognostic Index for Patients with Brain Metastases—A Population-Based Multi-Centre Study;Cancers;2023-06-13